AXA/2025/FY/Earnings presentation: Difference between revisions
Content deleted Content added
doc_archive: publish snjra2xp9r (.md link) |
doc_archive: publish snjra2xp9r |
||
Line 10:
| pages = 49
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| summary_md =
| intro_sentence = This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages).
| wide = yes
Line 21:
=== Full Year 2025 Earnings Presentation ===
{{chunk|doc=snjra2xp9r|c=1|p=1}}
====== Presentation date ======
* The presentation date is February 26, [[Definition:Year 2026|2026]].
=== Full Year 2025 Earnings ===
{{chunk|doc=snjra2xp9r|c=2|p=2}}
======
* Certain statements in the presentation are forward-looking, including predictions of future events, trends, plans, expectations, or objectives, and other non-historical information.
* Forward-looking statements are identified by words like "expects", "anticipates", "may", "plan," "target", "would", and "could".
* Statements regarding expected [[Definition:Underlying earnings per share|underlying earnings per share]] (UEPS) growth for [[Definition:Year 2026|2026]] are forward-looking statements providing one-off guidance for the last year of the Group’s current strategic plan.
* These statements are based on Management’s current views and intentions and are subject to change.
* Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties outside AXA’s control, which can cause actual results to differ materially.
* Each forward-looking statement is valid only at the date of the presentation.
* For important factors, risks, and uncertainties affecting AXA’s business and/or results, refer to Part 5 - “Risk Factors and Risk Management” of AXA’s Universal Registration Document for the year ended December 31, 2024 (the “2024 Universal Registration Document”).
* AXA disclaims any obligation to publicly update or revise forward-looking statements, except as required by applicable laws and regulations.
* The presentation refers to non-GAAP financial measures, or alternative performance measures (APMs), used by Management for analyzing operating trends, financial performance, and position.
* These non-GAAP financial measures generally have no standardized meaning and may not be comparable to measures used by other companies.
* Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Group’s consolidated financial statements prepared in accordance with IFRS.
* "[[Definition:Underlying earnings|Underlying earnings]]", UEPS (“underlying earnings per share”), “underlying return on equity”, “combined ratio”, and “debt gearing” are APMs as defined in ESMA’s guidelines and the AMF’s related position statement issued in 2015.
* AXA provides a reconciliation of APMs to related financial statement items and/or their calculation methodology in its Activity Report as of December 31, 2025 (“AXA’s 2025 Activity Report”), under the heading “USE OF NON-GAAP AND ALTERNATIVE PERFORMANCE MEASURES”.
* Further information on non-GAAP financial measures is available in the Glossary in AXA’s 2025 Activity Report.
* AXA’s Activity Report as of December 31, 2025, is available on the AXA Group website (www.axa.com).
* AXA’s consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA’s statutory auditors.
{{chunk|doc=snjra2xp9r|c=3|p=3}}
====== Presentation
* The presentation includes "[[Definition:Full year 2025|FY25]] Highlights
* "FY25 Business Performance
* "FY25 Financial Performance
== FY25 Highlights ==
{{chunk|doc=snjra2xp9r|c=4|p=4}}
======
* Thomas Buberl is the Group CEO.
Line 65:
{{chunk|doc=snjra2xp9r|c=5|p=5}}
====== Financial performance
* Revenues +6% vs. [[Definition:Full year 2024|FY24]]
* [[Definition:Underlying earnings per share|Underlying EPS]] +8% vs. FY24
*
* Solvency II ratio 224% FY25
{{chunk|doc=snjra2xp9r|c=6|p=5}}
====== Shareholder returns and future outlook ======
* Delivering value for shareholders with +8% DPS growth and EUR 1.25bn annual [[Definition:Share buyback|share buyback]]
* Confident to deliver [[Definition:Underlying earnings per share|underlying EPS]] growth at the upper end of the 6%-8% [[Definition:Target range|target range]] for [[Definition:Year 2026|2026]]
{{chunk|doc=snjra2xp9r|c=7|p=5}}
====== Full Year 2025 – Excellent performance ======
{{fn note|1=1|2=Based on the dividend proposed by
{{fn note|1=2|2=Following
=== Executing the plan on growth, margin and efficiency ===
{{chunk|doc=snjra2xp9r|c=8|p=6}}
======
<div style="overflow-x:auto">
{| id="t1" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying earnings
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
|-
| style="text-align:left" | Underlying earnings excluding AXA IM
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | +9%
|}
</div>
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%)
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency
* Scaling the business: Continued investments in growth and technology
* Consistent earnings growth while enhancing reserve prudence
{{fn note|1=1|2=Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX.}}
=== Diversified franchise, well positioned in an attractive industry ===
Line 116 ⟶ 119:
==== Secular trends fueling demand across businesses ====
{{chunk|doc=snjra2xp9r|c=
======
<div
{| id="t2" class="wikitable fintable"
|-
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Life
| style="text-align:right" | 33%
|-
| style="text-align:left" | Health
| style="text-align:right" | 17%
|-
| style="text-align:left" | Large & Specialty
| style="text-align:right" | 17%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|}
</div>
{{chunk|doc=snjra2xp9r|c=
======
* Protection gaps and emerging corporate risks are driving demand
* Demographics are driving demand for private retirement and healthcare.
==== Our right to win ====
{{chunk|doc=snjra2xp9r|c=
====== Competitive advantages ======
Line 145 ⟶ 160:
* Technical expertise in pricing and underwriting risks
* Scale offering cost advantage
{{chunk|doc=snjra2xp9r|c=12|p=7}}
====== Our right to win ======
{{fn note|1=1|2=Pie chart represents FY25 gross written premium split excluding AXA IM and holdings.}}
=== Laying the foundation for the next plan ===
{{chunk|doc=snjra2xp9r|c=13|p=8}}
======
* Clear tech and AI roadmap
* Driving efficiency
* Enhancing capital allocation discipline
* Building resilience
* Confidence in sustaining earnings growth
== FY25 Business Performance ==
{{chunk|doc=snjra2xp9r|c=14|p=
======
* Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology.
=== Strong delivery across our businesses ===
Line 170 ⟶ 190:
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! style="text-align:right" | Gross written premiums
! style="text-align:right" | Underlying earnings
|}
</div>
<tr><td>France (27% of total [[Definition:Gross written premiums|GWP]]{{fn ref|1}})</td><td>+6% to €31bn</td><td>+7% to €2.2bn</td></tr>
<tr><td>Europe (38% of total GWP{{fn ref|1}})</td><td>+6% to €43bn</td><td>+9% to €3.5bn</td></tr>
<tr><td>AXA XL (17% of total GWP{{fn ref|1}})</td><td>+4% to €19bn</td><td>+9% to €1.9bn</td></tr>
<tr><td>Asia, Africa & EME-LATAM (18% of total GWP{{fn ref|1}})</td><td>+13% to €20bn</td><td>+6% to €1.5bn</td></tr>
</table>
{{fn note|1=1|2=FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}}
=== P&C – Strong margins, confidence in sustaining growth ===
{{chunk|doc=snjra2xp9r|c=16|p=11}}
======
* [[Definition:Gross written premiums|Gross Written Premiums]] (GWP) were EUR 58bn.
* GWP mix includes Retail, SME & Mid-market, and AXA XL (Large & Specialty).
{{chunk|doc=snjra2xp9r|c=17|p=11}}
======
<div style="overflow-x:auto">
{| id="t4" class="wikitable"
|-
! style="text-align:left" |
! style="text-align:left" | 2025
! style="text-align:left" | Beyond 2025
|-
| style="text-align:left" | Retail and SME & Mid-market
| style="text-align:left" | Growing volumes while expanding margins
| style="text-align:left" | Investing to improve customer retention & expanding distribution footprint
|-
| style="text-align:left" | AXA XL (Large & Specialty)
| style="text-align:left" | Profitable growth with stable margins
| style="text-align:left" | Capitalizing on attractive growth opportunities and continued cycle management
|}
</div>
{{chunk|doc=snjra2xp9r|c=18|p=11}}
======
* [[Definition:Underlying earnings|Underlying earnings]]: +9% to EUR 5.9bn
* Continued progress on efficiency
* Higher investment income
* Data & AI to further enhance customer experience & technical excellence
{{chunk|doc=snjra2xp9r|c=19|p=11}}
====== P&C – Strong margins, confidence in sustaining growth ======
{{fn note|1=1|2=Includes AXA XL Re premiums of €2.6bn.}}
{{fn note|1=2|2=Change FY25 vs. FY24 at constant FX.}}
=== L&H – Good momentum, well positioned to capture growth opportunities ===
{{chunk|doc=snjra2xp9r|c=
====== GWP by Short-term and Long-term ======
<div
{| id="t5" class="wikitable"
|-
| style="text-align:left" | Short-term
| style="text-align:right" | Long-term
|}
</div>
==== 2025 Beyond 2025 ====
{{chunk|doc=snjra2xp9r|c=21|p=12}}
====== Strategic priorities for 2025 and Beyond 2025 ======
* Long-term business:
** 2025: Accelerating net flows in Savings at attractive margins
** Beyond 2025: Capturing savings & retirement opportunity, sourcing best asset management products for customers
* Short-term business:
** 2025: Growing technical results while absorbing Mexico VAT impact
** Beyond 2025: Capitalizing on demand for health & protection while further improving margins
* [[Definition:Underlying earnings|Underlying earnings]] +7% to EUR 3.5bn
* Focus on cost reduction
* Increasing penetration of Protection riders in Savings offerings
* Leveraging AI to reduce claims leakage & improve customer outcomes in Health
{{chunk|doc=snjra2xp9r|c=22|p=12}}
====== 2025 Beyond 2025 ======
{{fn note|1=1|2=Change FY25 vs. FY24 at constant FX.}}
Line 294 ⟶ 283:
== FY25 Financial Performance ==
{{chunk|doc=snjra2xp9r|c=
====== Group CFO ======
Line 301 ⟶ 290:
=== P&C – Continued disciplined growth ===
{{chunk|doc=snjra2xp9r|c=24|p=14}}
====== Currency notation ======
* All figures are in EUR billion.
==== GWP & Other Revenues ====
{{chunk|doc=snjra2xp9r|c=
====== GWP &
<div style="overflow-x:auto">
{| id="t6" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | o/w pricing{{fn ref|1}}
! class="col-s" style="text-align:right" | o/w volume{{fn ref|2}}
|-
| style="text-align:left" | Commercial lines
| rowspan="3" style="text-align:right" | 56.5
| style="text-align:right" | 35.8
| style="text-align:right" | +4%
| style="text-align:right" | +2%
| style="text-align:right" | +2%
|-
| style="text-align:left" | AXA XL Reinsurance
| style="text-align:right" | 2.6
| style="text-align:right" | +8%
| style="text-align:right" | +0.3%
| style="text-align:right" | +7%
|-
| style="text-align:left" | Retail lines
| style="text-align:right" | 19.7
| style="text-align:right" | +7%
| style="text-align:right" | +5%
| style="text-align:right" | +2%
|-
| style="text-align:left" | Total
| style="text-align:right" | 56.5
| style="text-align:right" | 58.0
| style="text-align:right" | +5%
| style="text-align:right" |
| style="text-align:right" |
|}
</div>
{{chunk|doc=snjra2xp9r|c=
====== Commercial
* Continued pricing momentum and volume growth in Mid-market and SME.
* Growth in lines of business with attractive margins
* Growth supported by alternative capital.
* Favorable pricing trends and strong growth in net new contracts (+1.7m in [[Definition:Full year 2025|FY25]]).
{{chunk|doc=snjra2xp9r|c=
====== GWP & Other Revenues ======
Line 345 ⟶ 356:
==== Combined ratio ====
{{chunk|doc=snjra2xp9r|c=
====== Combined ratio ======
<div
{| id="t7" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Combined ratio (total)
| style="text-align:right" | 91.0%
|-
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat)
| style="text-align:right" | 67.4%
| style="text-align:right" | 67.0%
|-
| style="text-align:left" | Expense ratio
| style="text-align:right" | 25.0%
| style="text-align:right" | 24.8%
|-
| style="text-align:left" | Nat Cat
| style="text-align:right" | 3.8%
| style="text-align:right" | 3.4%
|-
| style="text-align:left" | Prior year reserve development
| style="text-align:right" | -1.6%
| style="text-align:right" | -1.1%
|-
| style="text-align:left" | Discount
| style="text-align:right" | -3.6%
| style="text-align:right" | -3.5%
|}
</div>
{{chunk|doc=snjra2xp9r|c=
======
* Undiscounted current year loss ratio
* Margin expansion in Commercial lines SME & mid-market business and Personal lines due to favorable pricing.
* AXA XL Insurance margins stable at attractive levels, reflecting disciplined cycle management.
* Expense ratio improved due to efficiency measures, while continuing investment in growth initiatives and technology.
{{chunk|doc=snjra2xp9r|c=30|p=15}}
====== Nat Cat and reserve management ======
* Nat Cat charges were below the normalized load.
*
* Reserve prudence
=== P&C – Earnings growth from higher underwriting and financial result ===
{{chunk|doc=snjra2xp9r|c=
====== P&C earnings growth ======
* P&C earnings
* This growth was driven by a higher underwriting result and a higher financial result.
{{chunk|doc=snjra2xp9r|c=32|p=16}}
====== Underlying earnings waterfall by step ======
<div style="overflow-x:auto">
{| id="t8" class="wikitable fintable"
|-
! style="text-align:left" | Step
! class="col-s" style="text-align:right" | Value
|-
| style="text-align:left" | FY24
| style="text-align:right" | 5,510
|-
| style="text-align:left" | Volume growth
| style="text-align:right" | +292
|-
| style="text-align:left" | Margin improvement
| style="text-align:right" | +189
|-
| style="text-align:left" | Investment income
| style="text-align:right" | +435
|-
| style="text-align:left" | Insurance finance expenses
| style="text-align:right" | -235
|-
| style="text-align:left" | Tax
| style="text-align:right" | -169
|-
| style="text-align:left" | Affiliates, FX & other
| style="text-align:right" | -150
|-
| style="text-align:left" | FY25
| style="text-align:right" | 5,872
|}
</div>
{{chunk|doc=snjra2xp9r|c=33|p=16}}
====== P&C earnings growth ======
* P&C earnings grew +9%.
* Growth was driven by the underwriting result.
* Growth was driven by the financial result.
{{chunk|doc=snjra2xp9r|c=34|p=16}}
====== Underwriting result drivers ======
* The underwriting result improved due to strong volume growth.
* The underwriting result improved due to an enhanced all-year combined ratio.
* The underwriting result improved while enhancing reserve prudence.
{{chunk|doc=snjra2xp9r|c=35|p=16}}
======
* Investment income increased due to higher volumes.
* Investment income increased due to better reinvestment yields on fixed income assets.
* The unwind of discount of claims reserves was higher, in line with guidance.
{{chunk|doc=snjra2xp9r|c=36|p=16}}
======
* There was an unfavorable forex impact, notably due to USD depreciation vs. EUR.
{{chunk|doc=snjra2xp9r|c=37|p=16}}
======
{{fn note|1=1|2=Change at constant FX. 1. Underwriting result includes expenses.}}
=== Life & Health – Strong growth in premiums, positive net flows ===
{{chunk|doc=snjra2xp9r|c=38|p=17}}
======
<div style="overflow-x:auto">
{| id="t9" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Growth
|-
| style="text-align:left" | Protection
| style="text-align:right" |
| style="text-align:right" | 17.3
| style="text-align:right" | +11%
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" |
| style="text-align:right" | 9.3
| style="text-align:right" | +13%
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" |
| style="text-align:right" | 9.0
| style="text-align:right" | +7%
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" |
| style="text-align:right" | 1.9
| style="text-align:right" | -7%
|-
| style="text-align:left" | Total
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
|}
</div>
{{chunk|doc=snjra2xp9r|c=39|p=17}}
======
<div
{| id="t10" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Growth
|-
| style="text-align:left" | Individual
| style="text-align:right" |
| style="text-align:right" | 10.5
| style="text-align:right" | +6%
|-
| style="text-align:left" | Group
| style="text-align:right" |
| style="text-align:right" | 8.5
| style="text-align:right" | +4%
|-
| style="text-align:left" | Total
| style="text-align:right" | 17.5
| style="text-align:right" | 19.0
| style="text-align:right" | +5%
|}
</div>
{{chunk|doc=snjra2xp9r|c=40|p=17}}
======
<div style="overflow-x:auto">
{| id="t11" class="wikitable fintable"
|-
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Flow (€bn)
|-
| style="text-align:left" | Protection
| style="text-align:right" | +4.9
|-
| style="text-align:left" | Health
| style="text-align:right" | +2.7
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" | +1.5
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | +1.2
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | -5.0
|}
</div>
{{chunk|doc=snjra2xp9r|c=41|p=17}}
======
* Employee Benefits premiums: EUR 12.9bn (+4% vs. [[Definition:Full year 2024|FY24]])
{{chunk|doc=snjra2xp9r|c=42|p=17}}
====== Life & Health
{{fn note|1=1|2=Change at constant scope and FX. Including both short-term and long-term Employee Benefits GWP and other revenues.}}
=== Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
{{chunk|doc=snjra2xp9r|c=43|p=
======
* All figures are in EUR billion.
{{chunk|doc=snjra2xp9r|c=44|p=
======
<div style="overflow-x:auto">
{| id="t12" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Protection & Health
| rowspan="4" style="text-align:right" | 50.9
| style="text-align:right" | 31.4
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" | 8.5
|-
| style="text-align:left" | Capital-light G/A
| style="text-align:right" | 7.8
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | 1.7
|-
| style="text-align:left" | Total
| style="text-align:right" | 50.9
| style="text-align:right" | 49.4
|-
| style="text-align:left" | Change
| style="text-align:right" |
| style="text-align:right" | -2%
|-
| style="text-align:left" | Protection & Health change
| style="text-align:right" |
| style="text-align:right" | -4%
|-
| style="text-align:left" | Unit-Linked change
| style="text-align:right" |
| style="text-align:right" | +18%
|-
| style="text-align:left" | Capital-light G/A change
| style="text-align:right" |
| style="text-align:right" | -10%
|-
| style="text-align:left" | Traditional G/A change
| style="text-align:right" |
| style="text-align:right" | -10%
|}
</div>
{{chunk|doc=snjra2xp9r|c=45|p=18}}
======
<div style="overflow-x:auto">
{| id="t13" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | NB CSM (pre-tax)
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
|-
| style="text-align:left" | Change
| style="text-align:right" |
| style="text-align:right" | +3%
|}
</div>
{{chunk|doc=snjra2xp9r|c=46|p=18}}
====== NBV (post-tax) by FY ======
<div
{| id="t14" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | NBV (post-tax)
| style="text-align:right" | 2.3
| style="text-align:right" | 2.2
|-
| style="text-align:left" | Change
| style="text-align:right" |
| style="text-align:right" | stable
|-
| style="text-align:left" | NBV margin
| style="text-align:right" | 4.4%
| style="text-align:right" | 4.5%
|}
</div>
{{chunk|doc=snjra2xp9r|c=47|p=18}}
======
* PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes.
* NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits.
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.
{{chunk|doc=snjra2xp9r|c=48|p=18}}
====== Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ======
{{fn note|1=1|2=Change at constant scope and FX.}}
=== Life & Health – Growth in new business driving Normalized CSM growth ===
{{chunk|doc=snjra2xp9r|c=49|p=19}}
====== New business CSM ======
* New business CSM: EUR 2.2bn
==== Contractual Service Margin rollforward ====
{{chunk|doc=snjra2xp9r|c=
====== Contractual Service Margin rollforward (In Euro billion) ======
<div
{| id="t15" class="wikitable"
|-
! style="text-align:left" | FY24
! style="text-align:right" | New business CSM
! style="text-align:left" | Underlying return on in-force
! style="text-align:right" | CSM release
! style="text-align:right" | Economic variance
! style="text-align:right" | Operating variance
! style="text-align:right" | Affiliates, FX & other
! style="text-align:right" | FY25
|}
</div>
<tr><td>33.6</td><td>+2.2</td><td>+1.3</td><td>-3.0</td><td>+0.6</td><td>-0.3</td><td>-1.4</td><td>33.0</td></tr>
<tr><td>o/w Life: 25.8</td><td></td><td></td><td></td><td></td><td></td><td></td><td>25.4</td></tr>
<tr><td>o/w Health: 7.7</td><td></td><td></td><td></td><td></td><td></td><td></td><td>7.6</td></tr>
</table>
{{chunk|doc=snjra2xp9r|c=
====== Normalized CSM growth and drivers ======
* Normalized CSM growth: +2%
* Normalized CSM up +2%, with CSM release growth reflecting better margins
* New business CSM growth impacted by higher rates
* Economic variance reflects government spreads tightening and positive equity market returns
* Operating variance driven by better margins and net flows, more than offset by a reduction in the duration of Group Life business in Switzerland
* [[Definition:Foreign exchange|FX]] impact mainly from JPY and HKD depreciation
{{chunk|doc=snjra2xp9r|c=52|p=19}}
====== Contractual Service Margin rollforward ======
{{fn note|1=1|2=Change at constant scope and FX.}}
=== Life & Health – Strong momentum in both short-term and long-term business ===
{{chunk|doc=snjra2xp9r|c=
======
* All
==== Underlying Earnings ====
{{chunk|doc=snjra2xp9r|c=
====== Underlying Earnings (In Euro million) ======
<div style="overflow-x:auto">
{| id="t16" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! style="text-align:left" | Short-term technical margin
! style="text-align:left" | Long-term result incl. CSM release
! class="col-s" style="text-align:right" | Financial result
! class="col-s" style="text-align:right" | Tax, FX and others
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Short-term technical margin
| style="text-align:right" | 415
| style="text-align:left" | +60
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 479
|-
| style="text-align:left" | Long-term result incl. CSM release
| style="text-align:right" | 2,680
| style="text-align:left" |
| style="text-align:left" | +156
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 2,804
|-
| style="text-align:left" | Financial result
| style="text-align:right" | 975
| style="text-align:left" |
| style="text-align:left" |
| style="text-align:right" | -11
| style="text-align:right" |
| style="text-align:right" | 946
|-
| style="text-align:left" | Tax & others
| style="text-align:right" | -748
| style="text-align:left" |
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | -27
| style="text-align:right" | -728
|-
| style="text-align:left" | Total
| style="text-align:right" | 3,323
| style="text-align:left" |
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 3,501
|}
</div>
{{chunk|doc=snjra2xp9r|c=55|p=20}}
====== Underlying Earnings ======
* [[Definition:Underlying earnings|Underlying Earnings]]: +7%
{{chunk|doc=snjra2xp9r|c=56|p=20}}
====== in billions ======
<div style="overflow-x:auto">
{| id="t17" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-m" style="text-align:right" | Change at constant FX
|-
| style="text-align:left" | o/w Life
| style="text-align:right" | 2.6
| style="text-align:right" | 2.7
| style="text-align:right" | +4% vs. FY24
|-
| style="text-align:left" | o/w Health
| style="text-align:right" | 0.7
| style="text-align:right" | 0.8
| style="text-align:right" | +17% vs. FY24
|}
</div>
{{chunk|doc=snjra2xp9r|c=
======
* Short-term technical margin was strong, reflecting underwriting and claims initiatives.
*
* Long-term results were higher due to an increase in CSM release (+8%).
* The increase in CSM release reflects growth in the reserve base, including from favorable equity market performance, and better margins.
{{chunk|doc=snjra2xp9r|c=
======
{{fn note|1=1|2=Change at constant FX.}}
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
{{chunk|doc=snjra2xp9r|c=
====== Net income by business
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
Line 653 ⟶ 908:
</div>
{{chunk|doc=snjra2xp9r|c=
======
*
* Holding cost was stable and is expected to remain at the current level in [[Definition:Year 2026|2026]].
* Net
*
==== Underlying earnings per share ====
{{chunk|doc=snjra2xp9r|c=61|p=21}}
====== Underlying earnings per share ======
* [[Definition:Underlying earnings per share|Underlying earnings per share]] are presented in Euro.
{{chunk|doc=snjra2xp9r|c=62|p=21}}
====== Underlying earnings per share (In Euro) ======
<div style="overflow-x:auto">
{| id="t19" class="wikitable fintable"
|-
! style="text-align:left" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | 3.59
| style="text-align:right" | 3.86
| style="text-align:right" | +8%
|}
</div>
{{chunk|doc=snjra2xp9r|c=
====== Underlying
* [[Definition:Underlying earnings per share|Underlying EPS]] growth: +6% from earnings growth
* Underlying EPS growth: +3% from [[Definition:Capital management|
* Underlying EPS growth: -2% from forex
*
{{chunk|doc=snjra2xp9r|c=
======
{{fn note|1=1|2=Change at constant FX for underlying earnings and net income. Change on reported basis for underlying earnings per share.}}
=== Shareholders' Equity ===
==== Shareholders' equity ====
{{chunk|doc=snjra2xp9r|c=65|p=22}}
====== Shareholders' equity<sup>1</sup> ======
<div style="overflow-x:auto">
{| id="t20" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | HY25
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Total
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
| style="text-align:right" | 47.2
|-
| style="text-align:left" | SHE (excl. OCI)
| style="text-align:right" | 58.0
| style="text-align:right" | 52.7
| style="text-align:right" | 54.0
|-
| style="text-align:left" | Net OCI
| style="text-align:right" | -8.1
| style="text-align:right" | -7.2
| style="text-align:right" | -6.8
|-
| style="text-align:left" | SHE (excl. OCI & undated subordinated debt)
| style="text-align:right" | 53.2
| style="text-align:right" | 47.0
| style="text-align:right" | 49.4
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 23.4%
| style="text-align:right" | 22.3%
|-
| style="text-align:left" | Underlying ROE
| style="text-align:right" | 15.2%
| style="text-align:right" | 17.5%
| style="text-align:right" | 16.0%
|}
</div>
{{chunk|doc=snjra2xp9r|c=
====== Shareholders' equity ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
Line 775 ⟶ 1,050:
|}
</div>
{{fn note|1=1|2=Shareholders' equity Group share. Full Year 2025 Earnings}}
=== Higher organic cash remittance and robust cash position at Holding ===
{{chunk|doc=snjra2xp9r|c=67|p=23}}
====== Cash remittance and position ======
* In EUR billion
==== Net Cash Remittance ====
{{chunk|doc=snjra2xp9r|c=
====== Net Cash Remittance ======
<div
{| id="t22" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Proceeds related to in-force treaties{{fn ref|2}}
| style="text-align:right" | 0.6
| style="text-align:right" |
|-
| style="text-align:left" | Ordinary cash remittance
| style="text-align:right" | 7.1
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Total
| style="text-align:right" | 7.7
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Remittance ratio{{fn ref|1}}
| style="text-align:right" | 82%
| style="text-align:right" | 82%
|}
</div>
{{chunk|doc=snjra2xp9r|c=
====== Net Cash Remittance ======
<div style="overflow-x:auto">
{| id="
|-
|-
| style="text-align:left" | Net cash remittance from subsidiaries
Line 822 ⟶ 1,120:
| style="text-align:right" | +3.1
|-
|}
</div>
{{fn note|1=1|2=
{{fn note|1=2|2=
=== Solvency II at 224% ===
{{chunk|doc=snjra2xp9r|c=
======
* Foreseeable [[Definition:Dividend|dividends]]: EUR -4.8bn
* Provision for annual [[Definition:Share buyback|share buyback]] for [[Definition:Year 2026|2026]]: EUR -1.25bn
{{chunk|doc=snjra2xp9r|c=
======
<div
{| id="t24" class="wikitable"
|-
! style="text-align:left" | FY24
! style="text-align:left" | Regulatory & model changes
! style="text-align:left" | Normalized capital generation
! style="text-align:right" | Operating variance
! style="text-align:right" | Economic variance & FX
! style="text-align:left" | Dividend & annual share buyback
! style="text-align:left" | Management actions, debt & other
! style="text-align:right" | FY25
|}
</div>
{{chunk|doc=snjra2xp9r|c=
====== Solvency II ratio movements ======
* Solvency II ratio: 55.9 (reported)
* Solvency II ratio movements: +0.2 from operating return; +8.8 from market impacts; -0.4 from [[Definition:Capital management|capital management]]; -2.1 from regulatory changes; -6.0 from other impacts; -0.1 from [[Definition:Foreign exchange|FX]]
* Solvency II ratio at period end: 56.4 (reported)
{{chunk|doc=snjra2xp9r|c=73|p=24}}
====== Solvency II ratio ======
<div style="overflow-x:auto">
{| id="t25" class="wikitable"
|-
! style="text-align:left" | FY24
! style="text-align:left" | Regulatory & model changes
! style="text-align:left" | Normalized capital generation
! style="text-align:right" | Operating variance
! style="text-align:right" | Economic variance & FX
! style="text-align:left" | Dividend & annual share buyback
! style="text-align:left" | Management actions, debt & other
! style="text-align:right" | FY25
|}
</div>
{{chunk|doc=snjra2xp9r|c=
====== Solvency II
* Solvency II ratio was 216%.
* The ratio increased by +28pts due to operating return.
* The ratio decreased by -1pt due to market impacts.
* The ratio increased by +4pts due to [[Definition:Capital management|capital management]].
* The ratio decreased by -24pts due to regulatory changes.
* The ratio increased by +2pts due to other effects.
* The final Solvency II ratio was 224%.
{{chunk|doc=snjra2xp9r|c=75|p=24}}
====== Solvency Capital Requirement (SCR) ======
<div style="overflow-x:auto">
{| id="t26" class="wikitable"
|-
! style="text-align:left" | FY24
! style="text-align:left" | Regulatory & model changes
! style="text-align:left" | Normalized capital generation
! style="text-align:right" | Operating variance
! style="text-align:right" | Economic variance & FX
! style="text-align:left" | Dividend & annual share buyback
! style="text-align:left" | Management actions, debt & other
! style="text-align:right" | FY25
|}
</div>
{{chunk|doc=snjra2xp9r|c=
====== Solvency II
* Solvency II ratio bridge: 25.9 (start); 0.0 (operating capital generation); +0.6 (market impacts); 0.0 (non-operating items); -1.2 (
==== Key sensitivities ====
{{chunk|doc=snjra2xp9r|c=77|p=24}}
====== Impact by scenario ======
<div style="overflow-x:auto">
{| id="t27" class="wikitable fintable"
|-
! style="text-align:left" | Scenario
! class="col-s" style="text-align:right" | Impact
|-
| style="text-align:left" | Ratio as of December 31, 2025
| style="text-align:right" | 224%
|-
| style="text-align:left" | Interest rate +50bps
| style="text-align:right" | +2 pts
|-
| style="text-align:left" | Interest rate -50bps
| style="text-align:right" | -1 pt
|-
| style="text-align:left" | Corporate spreads +50bps
| style="text-align:right" | -1 pt
|-
| style="text-align:left" | Euro Sovereign spreads +50bps{{fn ref|1}}
| style="text-align:right" | -1 pt
|-
| style="text-align:left" | Credit migration{{fn ref|2}}
| style="text-align:right" | +2 pts
|-
| style="text-align:left" | Listed Equity (excl. PE & Infra) +25%
| style="text-align:right" | -7 pts
|-
| style="text-align:left" | Listed Equity (excl. PE & Infra) -25%
| style="text-align:right" | -4 pts
|-
| style="text-align:left" | PE & Infra +25%
| style="text-align:right" | +14 pts
|-
| style="text-align:left" | PE & Infra -25%
| style="text-align:right" | -19 pts
|-
| style="text-align:left" | Inflation swap curve +50bps
| style="text-align:right" | -5 pts
|}
</div>
{{fn note|1=1|2=Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures).}}
Line 892 ⟶ 1,261:
=== Solvency II – impact of the end of grandfathering period and Solvency II revision ===
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="
|-
| style="text-align:left" | Ratio as of 31/12/2025
Line 904 ⟶ 1,273:
| style="text-align:left" | Impact of the end of grandfathering period on January 1, 2026
| style="text-align:right" | -10pts to 215%
| style="text-align:left" |
|-
| style="text-align:left" | Impact of Solvency II revision to come into effect in 1Q27
| style="text-align:right" | +17pts{{fn ref|1|2=Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.}}
| style="text-align:left" |
|}
</div>
No change expected in organic capital generation<br/>
Additional capital flexibility
</td>
</tr>
</table>
{{fn note|1=1|2=Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.}}
== Conclusion ==
{{chunk|doc=snjra2xp9r|c=
======
* Thomas Buberl is the Group CEO.
Line 925 ⟶ 1,296:
=== Conclusion ===
{{chunk|doc=snjra2xp9r|c=
====== Business performance and outlook ======
*
* All businesses are in excellent shape, delivering strong growth and profitability.
* The diversified franchise is well-positioned to capture future growth opportunities.
*
== Q&A ==
{{chunk|doc=snjra2xp9r|c=81|p=28}}
====== Date ======
* February 26, [[Definition:Year 2026|2026]]
=== AXA Investor Relations – Keep in touch ===
==== Meet our management ====
{{chunk|doc=snjra2xp9r|c=82|p=29}}
====== Investor relations calendar ======
* March: Roadshows in Europe and US
* May 5: 1Q25 Activity Indicators in Paris
* June 2: BNP Paribas Exane CEO Conference in Paris
* June 2-4: Goldman Sachs European Financials Conference in Zurich
* July 31: HY26 [[Definition:Earnings release|Earnings Release]] in Paris
* September 21: AXA Investor Day in London
==== Contact us ====
{{chunk|doc=snjra2xp9r|c=
====== Investor Relations
* Investor Relations contact
* Investor Relations email: investor.relations@axa.com
==== Follow us ====
{{chunk|doc=snjra2xp9r|c=84|p=29}}
====== AXA website ======
* AXA website: www.axa.com
== Appendices ==
{{chunk|doc=snjra2xp9r|c=
======
* The document includes appendices on: Debt and Invested Assets; Additional P&C disclosures; Additional IFRS17 disclosures.
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
{{chunk|doc=snjra2xp9r|c=86|p=32}}
====== Gross financial debt and maturity breakdown ======
* All figures are in EUR billion.
==== Gross financial debt ====
{{chunk|doc=snjra2xp9r|c=
======
* Debt gearing: 20.6% (prior: 22.3%)
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="t29" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Jan 1st 2026
|-
| style="text-align:left" | Total
| style="text-align:right" | 19.2
| style="text-align:right" | 20.3
| style="text-align:right" | 20.3
|-
| style="text-align:left" | Tier 1
| style="text-align:right" | 4.8
| style="text-align:right" | 4.6
| style="text-align:right" | 3.2
|-
| style="text-align:left" | Tier 2
| style="text-align:right" | 10.8
| style="text-align:right" | 12.2
| style="text-align:right" | 11.3
|-
| style="text-align:left" | Senior debt
| style="text-align:right" | 3.5
| style="text-align:right" | 3.5
| style="text-align:right" | 5.8
|}
</div>
{{chunk|doc=snjra2xp9r|c=
======
* End of the grandfathering period
* EUR 0.4bn redeemed in Jan [[Definition:Year 2026|2026]]
==== Contractual maturity breakdown ====
{{chunk|doc=snjra2xp9r|c=90|p=32}}
====== Contractual maturity breakdown (In Euro billion) ======
<div style="overflow-x:auto">
{| id="t30" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | 2025
! class="col-s" style="text-align:right" | 2026
! class="col-s" style="text-align:right" | 2027
! class="col-s" style="text-align:right" | 2028
! class="col-s" style="text-align:right" | 2029
! class="col-s" style="text-align:right" | 2030
! class="col-s" style="text-align:right" | 2031-2039
! class="col-s" style="text-align:right" | ≥2040
! class="col-s" style="text-align:right" | Undated
|-
| style="text-align:left" | Senior debt
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 1.5
| style="text-align:right" | 0.5
| style="text-align:right" |
|-
| style="text-align:left" | Tier 2
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 0.5
| style="text-align:right" | 0.9
| style="text-align:right" | 0.7
| style="text-align:right" | 10.8
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Tier 1
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 4.6
| style="text-align:right" |
|}
</div>
{{chunk|doc=snjra2xp9r|c=
======
* Grandfathered debt is included in the contractual maturity breakdown.
{{chunk|doc=snjra2xp9r|c=
====== Tier 1 & Tier 2 by 2025, 2026, 2027, 2028, 2029, 2030, 2031-2039, ≥2040, Undated ======
<div
{| id="t31" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | 2025
! class="col-s" style="text-align:right" | 2026
! class="col-s" style="text-align:right" | 2027
! class="col-s" style="text-align:right" | 2028
! class="col-s" style="text-align:right" | 2029
! class="col-s" style="text-align:right" | 2030
! class="col-s" style="text-align:right" | 2031-2039
! class="col-s" style="text-align:right" | ≥2040
! class="col-s" style="text-align:right" | Undated
|-
| style="text-align:left" | Tier 1
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | 1.4
|-
| style="text-align:left" | Tier 2
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | 0.7
| style="text-align:right" | -
| style="text-align:right" | 0.2
| style="text-align:right" | -
|}
</div>
==== Economic maturity breakdown ====
{{chunk|doc=snjra2xp9r|c=93|p=32}}
====== Economic maturity breakdown by senior debt, Tier 2, Tier 1 ======
<div style="overflow-x:auto">
{| id="
|-
! class="col-s" style="text-align:right" | 2027
! class="col-s" style="text-align:right" | 2028
! class="col-s" style="text-align:right" | 2029
! class="col-s" style="text-align:right" | 2030
! class="col-s" style="text-align:right" | 2031-2039
! class="col-s" style="text-align:right" | ≥2040
! class="col-s" style="text-align:right" | Undated
|-
| style="text-align:left" |
| style="text-align:
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 1.5
| style="text-align:right" | 0.5
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:
| style="text-align:right" |
| style="text-align:right" | 2.4
| style="text-align:right" | 0.1
| style="text-align:right" | 0.5
| style="text-align:right" | 2.0
| style="text-align:right" | 6.4
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 0.9
| style="text-align:right" | 0.7
| style="text-align:right" | 0.4
| style="text-align:right" |
| style="text-align:right" | 4.0
|}
</div>
{{chunk|doc=snjra2xp9r|c=94|p=32}}
====== Grandfathered debt ======
* o/w Grandfathered debt
{{chunk|doc=snjra2xp9r|c=95|p=32}}
====== Tier 1 & Tier 2 by economic maturity ======
<div style="overflow-x:auto">
{| id="t33" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | 2025
! class="col-s" style="text-align:right" | 2026
! class="col-s" style="text-align:right" | 2027
! class="col-s" style="text-align:right" | 2028
! class="col-s" style="text-align:right" | 2029
! class="col-s" style="text-align:right" | 2030
! class="col-s" style="text-align:right" | 2031-2039
! class="col-s" style="text-align:right" | ≥2040
! class="col-s" style="text-align:right" | Undated
|-
| style="text-align:left" | Tier 1
| style="text-align:right" | -
| style="text-align:right" | 0.1
| style="text-align:right" | -
| style="text-align:right" | 0.1
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | 0.4
| style="text-align:right" | -
| style="text-align:right" | 0.8
|-
| style="text-align:left" | Tier 2
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | 0.7
| style="text-align:right" | 0.2
| style="text-align:right" | -
| style="text-align:right" | -
|}
</div>
{{fn note|1=1,2|2=1. Nominal debt. 2. In January 2026, AXA has called (i) the remaining T2 GF £139m due 2054 callable 2034 5.625% issued January 2014 and (ii) the T1 GF €250m perpetual callable 2010 floating issued January 2005.}}
{{fn note|1=3|2=3. Economic maturity is taking into account the first date of step up calls on institutionally placed subordinated debt. For Solvency 2 RT1 debt, that has no step-up, the undated nature of the instrument is retained for the purpose of this diagram. This should not be construed, nor relied upon, as an indication that the instrument will not be called for redemption when callable. Such decision will depend on several factors, including our capital and liquidity position and the refinancing economics at the prevailing time.}}
=== General Account Invested Assets ===
{{chunk|doc=snjra2xp9r|c=
======
* [[Definition:Full year 2025|FY25]] Total General Account invested assets Duration gap at -0.4 year
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="t34" class="wikitable"
|-
| style="text-align:left" | Fixed income
|-
| style="text-align:left" | Real estate
|-
| style="text-align:left" | Infrastructure equity
|-
| style="text-align:left" | Listed equities
|-
| style="text-align:left" | Private equity and hedge funds
|-
| style="text-align:left" | Cash
|-
| style="text-align:left" | Policy loans
|}
</div>
{{chunk|doc=snjra2xp9r|c=
====== Invested assets (100%) In Euro billion ======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
Line 1,237 ⟶ 1,682:
| style="text-align:right" | 0%
|-
|}
</div>
{{fn note|1=1|2=
{{fn note|1=2|2=
{{fn note|1=3|2=
{{fn note|1=4|2=
=== Structured and Private Credit assets ===
{{chunk|doc=snjra2xp9r|c=
====== Invested assets (100%) by Total Structured and Private Credit
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" | Invested assets (100%)<br/>In Euro billion
!
!
! style="text-align:
|}
</div>
<tr><td>Residential Mortgages</td><td>16</td><td>4%</td><td>- €6bn Dutch mortgages, NHG guaranteed<br>- €10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)</td></tr>
<tr><td>CLO & ABS</td><td>25</td><td>6%</td><td>- 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)</td></tr>
<tr><td>Infrastructure debt</td><td>8</td><td>2%</td><td>- Skewed towards resilient industries (Telecom, Utilities, Transport)</td></tr>
<tr><td>CRE debt</td><td>8</td><td>2%</td><td>- Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV</td></tr>
<tr><td>Mid-Market lending</td><td>10</td><td>2%</td><td>- Strong diversification with €8m average ticket<br>- Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation</td></tr>
<tr><td>Other</td><td>2</td><td>0%</td><td></td></tr>
<tr><td><strong>Total Structured and Private Credit Assets</strong></td><td><strong>69</strong></td><td><strong>15%</strong></td><td>o/w 54% participating</td></tr>
</table>
{{fn note|1=1|2=G/A: General Account}}
Line 1,304 ⟶ 1,722:
==== FY25 Fixed Income Reinvestment ====
{{chunk|doc=snjra2xp9r|c=
======
* Government bonds & related comprise 32% of the portfolio with an average rating of AA.
* Investment grade credit comprises 40% of the portfolio with an average rating of A.
* ABS/CLO/IG fund financing comprises 21% of the portfolio.
* Below investment grade credit comprises 7% of the portfolio.
* The total reinvestment amount is EUR 57bn.
==== FY25 Fixed Income Reinvestment Yield ====
{{chunk|doc=snjra2xp9r|c=
======
<div
{| id="t37" class="wikitable fintable"
|-
! style="text-align:left" | Public fixed income{{fn ref|1}}
! style="text-align:left" | Private & Structured fixed income{{fn ref|2}}
! class="col-s" style="text-align:right" | Total fixed income
|-
| style="text-align:left" | 3.5%
| style="text-align:left" | 4.7%
| style="text-align:right" | 3.9%
|}
</div>
{{chunk|doc=snjra2xp9r|c=102|p=35}}
====== FY25 fixed income reinvestment yield ======
* EUR 57bn fixed income invested at 3.9%
* Average duration of 9 years
* Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY)
* Gradual shift from alternative total return assets to Private & Structured credit
{{chunk|doc=snjra2xp9r|c=
======
{{fn note|1=1|2=Government and Corporate bonds and related.}}
{{fn note|1=2|2=Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid).}}
{{chunk|doc=snjra2xp9r|c=
======
* Additional P&C disclosures are on page 36.
* Additional IFRS17 disclosures are on page 41.
* Debt and Invested Assets disclosures are on page 31.
=== AXA XL Insurance – Large Commercial & Specialty business ===
==== Well diversified across lines of business and geographies ====
{{chunk|doc=snjra2xp9r|c=105|p=37}}
====== GWP by line of business ======
<div style="overflow-x:auto">
{| id="
|-
| style="text-align:left" |
| style="text-align:
|-
| style="text-align:left" |
| style="text-align:
|-
| style="text-align:left" |
| style="text-align:
|-
| style="text-align:left" |
| style="text-align:
|}
</div>
{{chunk|doc=snjra2xp9r|c=106|p=37}}
====== GWP by geography ======
<div style="overflow-x:auto">
{| id="t39" class="wikitable fintable"
|-
| style="text-align:left" | Americas
| style="text-align:right" | 46%
|-
| style="text-align:left" | Europe & APAC
| style="text-align:right" | 35%
|-
| style="text-align:left" | UK & Lloyds
| style="text-align:right" | 19%
|}
</div>
==== Leading market positions across lines ====
{{chunk|doc=snjra2xp9r|c=107|p=37}}
====== Commercial lines market position ======
* Top 3 globally in Multinational Programs, Marine, and Fine Art & Specie.
==== Managing the cycle to deliver consistent profitability ====
{{chunk|doc=snjra2xp9r|c=
====== Profitability
* Profitability vs. Ex-price growth (%)
** Professional lines: lower ex-price growth, lower profitability
** Casualty: medium ex-price growth, medium profitability
** Specialty (including Cyber): medium-high ex-price growth, medium-high profitability
** Property: high ex-price growth, high profitability
=== P&C – Focus on Reserves ===
Line 1,434 ⟶ 1,833:
==== Claims reserves ratio ====
{{chunk|doc=snjra2xp9r|c=
======
*
{{chunk|doc=snjra2xp9r|c=
====== Claims reserves ratio (Net undiscounted claims reserves/Net earned premiums) ======
<div
{| id="t40" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY18
! class="col-s" style="text-align:right" | FY19
! class="col-s" style="text-align:right" | FY20
! class="col-s" style="text-align:right" | FY21
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
! style="text-align:left" |
! colspan="5" style="text-align:center" | IFRS4
! colspan="4" style="text-align:center" | IFRS17
|-
| style="text-align:left" | Claims reserves ratio
| style="text-align:right" | 179%
| style="text-align:right" | 185%
| style="text-align:right" | 193%
| style="text-align:right" | 188%
| style="text-align:right" | 189%
| style="text-align:right" | 198%
| style="text-align:right" | 195%
| style="text-align:right" | 180%
| style="text-align:right" | 175%
|}
</div>
==== Technical reserves ratio ====
{{chunk|doc=snjra2xp9r|c=
======
*
{{chunk|doc=snjra2xp9r|c=
====== Technical reserves ratio (Net undiscounted technical reserves/Net earned premiums) ======
<div
{| id="t41" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY18
! class="col-s" style="text-align:right" | FY19
! class="col-s" style="text-align:right" | FY20
! class="col-s" style="text-align:right" | FY21
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
! style="text-align:left" |
! colspan="5" style="text-align:center" | IFRS4
! colspan="4" style="text-align:center" | IFRS17
|-
| style="text-align:left" | Technical reserves ratio
| style="text-align:right" | 213%
| style="text-align:right" | 227%
| style="text-align:right" | 233%
| style="text-align:right" | 226%
| style="text-align:right" | 227%
| style="text-align:right" | 234%
| style="text-align:right" | 232%
| style="text-align:right" | 216%
| style="text-align:right" | 210%
|}
</div>
{{fn note|1=1|2=Includes net undiscounted claims reserves and unearned premium reserves.}}
=== P&C – 2026 Simplified Group Nat Cat Reinsurance Program ===
{{chunk|doc=snjra2xp9r|c=
======
* All figures are in
==== Insurance segment (occurrence protection) ====
==== Reinsurance segment (illustrative) ====
{{chunk|doc=snjra2xp9r|c=
======
* Alternative Capital & Cat Bonds
{{chunk|doc=snjra2xp9r|c=
====== Capacity and Retention by peril ======
<div style="overflow-x:auto">
{| id="t42" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | EU Windstorm
! class="col-s" style="text-align:right" | Europe Flood
! class="col-s" style="text-align:right" | Europe Earthquake
! class="col-s" style="text-align:right" | NA Hurricane
! class="col-s" style="text-align:right" | NA Earthquake
! class="col-s" style="text-align:right" | Per other perils{{fn ref|3}}
|-
| style="text-align:left" | Capacity
| style="text-align:right" | 4.0bn
| style="text-align:right" | 2.1bn
| style="text-align:right" | 2.1bn
| style="text-align:right" | 1.2bn
| style="text-align:right" | 1.2bn
| style="text-align:right" |
|-
| style="text-align:left" | Retention
| style="text-align:right" | 600m
| style="text-align:right" | 450m
| style="text-align:right" | 400m
| style="text-align:right" | 600m{{fn ref|2}}
| style="text-align:right" | 600m{{fn ref|2}}
| style="text-align:right" | 400m
|}
</div>
{{chunk|doc=snjra2xp9r|c=116|p=39}}
====== Retention levels ======
*
{{chunk|doc=snjra2xp9r|c=
====== Reinsurance segment (illustrative) ======
{{fn note|1=1|2=Excludes local reinsurance covers;}}
Line 1,527 ⟶ 1,977:
=== P&C – AXA Group earnings deviation with different levels of Nat Cat cost in 2026 ===
{{chunk|doc=snjra2xp9r|c=
======
*
==== Group underlying earnings deviation to average Nat Cat charges in 2026
{{chunk|doc=snjra2xp9r|c=
======
* The table presents Nat Cat charges deviation net of reinsurance, post-tax and pre-tax.
{{chunk|doc=snjra2xp9r|c=120|p=40}}
====== Deviation by percentile and return period ======
<div style="overflow-x:auto">
{| id="t43" class="wikitable"
|-
! style="text-align:left" | Percentile
! style="text-align:right" | Return period
! style="text-align:right" | Deviation
|-
| style="text-align:left" | 95th
| style="text-align:right" | 1/20y (more severe)
| style="text-align:right" | €-1.2bn
|-
| style="text-align:left" | 90th
| style="text-align:right" | 1/10y
| style="text-align:right" | €-0.8bn
|-
| style="text-align:left" | 80th
| style="text-align:right" | 1/5y
| style="text-align:right" | €-0.4bn
|-
| style="text-align:left" | 50th
| style="text-align:right" | Median
| style="text-align:right" | €+0.1bn
|-
| style="text-align:left" | 20th
| style="text-align:right" | 1/5y
| style="text-align:right" | €+0.5bn
|-
| style="text-align:left" | 10th
| style="text-align:right" | 1/10y
| style="text-align:right" | €+0.7bn
|-
| style="text-align:left" | 5th
| style="text-align:right" | 1/20y
| style="text-align:right" | €+0.8bn
|}
</div>
{{chunk|doc=snjra2xp9r|c=121|p=40}}
====== Nat Cat charges deviation ======
* Negative deviation in approximately 40% of cases for more severe years.
* Positive deviation in approximately 60% of cases for less severe years.
==== Average Expected Nat Cat charges ====
{{chunk|doc=snjra2xp9r|c=122|p=40}}
====== Value & Estimated impact on GEP by year ======
<div style="overflow-x:auto">
{| id="t44" class="wikitable"
|-
! style="text-align:left" |
! style="text-align:right" | 2025
! style="text-align:right" | 2026
|-
| style="text-align:left" | Value (€bn)
| style="text-align:right" | 2.6
| style="text-align:right" | 2.7
|-
| style="text-align:left" | Estimated impact on GEP
| style="text-align:right" | ca. 4.5%
| style="text-align:right" | ca. 4.5%
|}
</div>
{{fn note|1=1|2=Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). Full Year 2025 Earnings}}
{{chunk|doc=snjra2xp9r|c=123|p=41}}
====== Additional disclosures ======
* Debt and Invested Assets are detailed on p.31
* Additional IFRS17 disclosures are on p.41
=== P&C – Margin Analysis ===
==== Technical Result ====
{{chunk|doc=snjra2xp9r|c=124|p=42}}
====== Pre-tax technical result ======
* All figures are in EUR million (pre-tax).
{{chunk|doc=snjra2xp9r|c=125|p=42}}
====== Current Accident Year Undiscounted Technical Margin ======
<div style="overflow-x:auto">
{| id="
|-
|-
| style="text-align:left" |
| style="text-align:
| style="text-align:right" |
|-
| style="text-align:left" | Gross Earned Premiums
| style="text-align:right" | 57,656
| style="text-align:right" | +6%
|-
| style="text-align:left" |
| style="text-align:
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:
| style="text-align:right" |
|}
</div>
{{chunk|doc=snjra2xp9r|c=126|p=42}}
====== Current Accident Year Discounting by FY25 ======
<div style="overflow-x:auto">
{| id="t46" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | <strong>Current Accident Year Discounting</strong>
| style="text-align:right" | 2,009
| style="text-align:right" | +115
|-
| style="text-align:left" | Discounting Ratio (in Combined Ratio points)
| style="text-align:right" | -3.5%
| style="text-align:right" | +0.0pt
|-
| style="text-align:left" | Current Accident Year Net Claims reserves
| style="text-align:right" | €19.0bn
| style="text-align:right" |
|-
| style="text-align:left" | Duration
| style="text-align:right" | 4.0 years
| style="text-align:right" |
|-
| style="text-align:left" | Current Accident Year Discount rate
| style="text-align:right" | 2.8%
| style="text-align:right" |
|}
</div>
{{chunk|doc=snjra2xp9r|c=127|p=42}}
====== Prior Years' Reserve Development (PYD) ======
<div style="overflow-x:auto">
{| id="t47" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | <strong>Prior Years' Reserve Development (PYD)</strong>
| style="text-align:right" | 622
| style="text-align:right" | -341
|-
| style="text-align:left" | PYD ratio
| style="text-align:right" | -1.1%
| style="text-align:right" | +0.7pt
|}
</div>
{{chunk|doc=snjra2xp9r|c=
======
* [[Definition:Full year 2025|FY25]] sensitivity to Current Accident Year
==== Financial Result ====
{{chunk|doc=snjra2xp9r|c=129|p=42}}
====== Pre-tax results ======
* All figures are in EUR million (pre-tax).
{{chunk|doc=snjra2xp9r|c=130|p=42}}
====== Investment income ======
<div style="overflow-x:auto">
{| id="t48" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | <strong>Investment Income</strong>
| style="text-align:right" | 3,988
| style="text-align:right" | +435
|-
| style="text-align:left" | FY25 Average Assets
| style="text-align:right" | €115bn
| style="text-align:right" |
|-
| style="text-align:left" | Asset book yield
| style="text-align:right" | 3.5%
| style="text-align:right" |
|-
| style="text-align:left" | FY25 Reinvestment yield{{fn ref|1}}
| style="text-align:right" | 4.3%
| style="text-align:right" |
|}
</div>
{{chunk|doc=snjra2xp9r|c=131|p=42}}
====== Insurance Finance Expenses ======
<div style="overflow-x:auto">
{| id="t49" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | <strong>Insurance Finance Expenses</strong>
| style="text-align:right" | -1,358
| style="text-align:right" | -235
|-
| style="text-align:left" | FY24 Reserves at locked-in rate
| style="text-align:right" | €71bn
| style="text-align:right" |
|-
| style="text-align:left" | Liability book yield
| style="text-align:right" | 1.9%
| style="text-align:right" |
|}
</div>
{{chunk|doc=snjra2xp9r|c=132|p=42}}
====== Insurance finance expenses ======
* 2026e Insurance Finance Expenses (pre-tax): ~ EUR -1.4bn
* Sensitivity of 2026e Insurance Finance Expenses to changes in 2025 current AY Discount:
Line 1,648 ⟶ 2,227:
** -25bps: ~ EUR +50m
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="t50" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-m" style="text-align:right" | Change
|-
| style="text-align:left" | <strong>Underlying Earnings before tax</strong>
| style="text-align:right" | 8,040
| style="text-align:right" | +681
|-
| style="text-align:left" | Tax
| style="text-align:right" | -2,060
| style="text-align:right" | -169
|-
| style="text-align:left" | Affiliates, Minority interests & Other
| style="text-align:right" | -108
| style="text-align:right" | -10
|-
| style="text-align:left" | <strong>Underlying Earnings</strong>
| style="text-align:right" | 5,872
| style="text-align:right" | +501
|-
| style="text-align:left" | <em>Growth vs. FY24 (at constant FX)</em>
| style="text-align:right" |
| style="text-align:right" | <em>+9%</em>
|}
</div>
{{fn note|1=1|2=Reinvestment yield on fixed income assets.}}
Line 1,656 ⟶ 2,264:
=== L&H – Margin Analysis ===
{{chunk|doc=snjra2xp9r|c=
====== Scope impact ======
*
==== Technical Result ====
{{chunk|doc=snjra2xp9r|c=
====== Pre-tax
*
{{chunk|doc=snjra2xp9r|c=
====== Short-term Technical
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
Line 1,678 ⟶ 2,286:
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | <b>Short-term Technical Margin</b>
| style="text-align:right" | <b>479</b>
| style="text-align:right" | <b>+60</b>
|-
| style="text-align:left" | Gross Earned Premiums
Line 1,689 ⟶ 2,297:
| style="text-align:right" | 97.2%
| style="text-align:right" | -0.1pts
|}
</div>
{{chunk|doc=snjra2xp9r|c=137|p=43}}
====== Long-term Technical Margin by CSM release and Technical experience ======
<div style="overflow-x:auto">
{| id="t52" class="wikitable fintable"
|-
|-
| style="text-align:left" | <b>Long-term Technical Margin</b>
| style="text-align:right" | <b>2,804</b>
| style="text-align:right" | <b>+156</b>
|-
| style="text-align:left" | CSM release
Line 1,703 ⟶ 2,323:
|}
</div>
{{chunk|doc=snjra2xp9r|c=138|p=43}}
====== Technical result adjustments ======
* The technical result includes the recapture of Laya.
{{chunk|doc=snjra2xp9r|c=139|p=43}}
====== FY25 CSM by sensitivities ======
<div style="overflow-x:auto">
{| id="t53" class="wikitable"
|}
</div>
(in Euro billion)</caption>
<tr><th></th><th>[[Definition:Full year 2025|FY25]]</th></tr>
<tr><td><b>Baseline</b></td><td>33.3</td></tr>
<tr><td>Interest rates +50bps</td><td>-0.8</td></tr>
<tr><td>Interest rates -50bps</td><td>0.6</td></tr>
<tr><td>Sovereign spreads +50bps</td><td>-1.9</td></tr>
<tr><td>Sovereign spreads -50bps</td><td>1.9</td></tr>
<tr><td>Corporate spread +50bps</td><td>-0.8</td></tr>
<tr><td>Corporate spread -50bps</td><td>0.7</td></tr>
<tr><td>Equities +25%</td><td>1.8</td></tr>
<tr><td>Equities -25%</td><td>-2.2</td></tr>
</table>
==== Financial Result ====
{{chunk|doc=snjra2xp9r|c=
====== Pre-tax
*
{{chunk|doc=snjra2xp9r|c=
====== Investment
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
!
!
|-
| style="text-align:left" | <b>Investment Income (non-VFA only)</b>
| style="text-align:right" | <b>2,484</b>
| style="text-align:right" | <b>-1</b>
|-
| style="text-align:left" | FY25 Average Assets
Line 1,736 ⟶ 2,381:
| style="text-align:right" | 3.8%
| style="text-align:right" |
|}
</div>
{{chunk|doc=snjra2xp9r|c=142|p=43}}
====== Insurance Finance Expenses (non-VFA only) ======
<div style="overflow-x:auto">
{| id="t55" class="wikitable"
|-
! style="text-align:left" |
! style="text-align:right" | FY25
! style="text-align:right" | Change
|-
| style="text-align:left" | <b>Insurance Finance Expenses (non-VFA only)</b>
| style="text-align:right" | <b>-1,538</b>
| style="text-align:right" | <b>-9</b>
|-
| style="text-align:left" | FY24 Reserves at locked-in rate
Line 1,751 ⟶ 2,408:
</div>
{{chunk|doc=snjra2xp9r|c=
======
<div style="overflow-x:auto">
{| id="
|-
! style="text-align:left" |
!
!
|-
| style="text-align:left" | <b>Underlying Earnings before tax</b>
| style="text-align:right" | <b>4,229</b>
| style="text-align:right" | <b>+205</b>
|-
| style="text-align:left" | Tax
Line 1,786 ⟶ 2,430:
| style="text-align:right" | -51
|-
| style="text-align:left" | <b>Underlying Earnings</b>
| style="text-align:right" | <b>3,501</b>
| style="text-align:right" | <b>+219</b>
|-
| style="text-align:left" | <i>Growth vs. FY24 (at constant FX)</i>
| style="text-align:right" |
| style="text-align:right" | +7%
Line 1,796 ⟶ 2,440:
</div>
{{fn note|1=1|2=Reinvestment yield on fixed income assets.}}
{{chunk|doc=snjra2xp9r|c=144|p=44}}
====== Additional disclosures ======
* Debt and Invested Assets disclosures are on p.31.
* Additional P&C disclosures are on p.36.
* Additional IFRS17 disclosures are on p.41.
=== Expanding AXA's role in society: AXA for Progress Index ===
{{chunk|doc=snjra2xp9r|c=145|p=45}}
====== Target and 2025 Result by Global Investor, Global Insurer, and Company ======
<div style="overflow-x:auto">
{| id="
|-
|-
! style="text-align:left" | Target
! style="text-align:right" | 2025 Result
! style="text-align:left" | Target
! style="text-align:left" | Target
! style="text-align:right" | 2025 Result
|-
| style="text-align:left" | €5bn{{fn ref|2}} in climate transition financing per year
| rowspan="2" style="text-align:right" | €6.4bn
| style="text-align:left" | €6bn{{fn ref|3}} in P&C GWP to support transition underwriting (cumulative 2024-2026)
| style="text-align:right" | €4.6bn
| style="text-align:left" | >80,000{{fn ref|6|2=Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026.}} AXA Group employees trained on climate adaptation by 2026
| style="text-align:right" | 46,420
|-
| style="text-align:left" | >
| style="text-align:right" |
| style="text-align:left" | 19,698 Cumulative 2024-2025
| style="text-align:right" | Contribute to Net-Zero -50%{{fn ref|7|2=Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030.}} by 2030 in absolute carbon emissions and offset of residual emissions{{fn ref|8|2=Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage).}}
| style="text-align:left" | -64% Reduction against 2019
|-
| style="text-align:left" |
| style="text-align:right" | €1.4bn
| style="text-align:left" | >20m{{fn ref|5|2=Low-income to mass market segments in emerging markets and modest income segments in mature markets.}} inclusive insurance customers by 2026
| style="text-align:right" | 20.6m
| style="text-align:left" | 50% Percentage of AXA Group employees engaged in volunteering activities by 2026
| style="text-align:right" | 56%
Line 1,932 ⟶ 2,501:
=== Sustainability Performance & Ratings ===
{{chunk|doc=snjra2xp9r|c=146|p=46}}
====== Sustainability ratings ======
* Dow Jones Best-in-Class Europe & World indices percentile: 97th in 2025
* MSCI score: AAA in 2025
* CDP score: B in 2025
* Sustainalytics ESG Risk Rating: 17.0 (Low risk) in 2025
* FTSE4Good Index Series score: 4.3/5 in 2025
{{chunk|doc=snjra2xp9r|c=147|p=46}}
====== Sustainability Performance & Ratings ======
{{fn note|1=1|2=The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares). Results as of February 6th, 2026.}}
=== Scope ===
{{chunk|doc=snjra2xp9r|c=
====== Scope
* France: includes insurance activities, banking activities, and holding.
* Europe: includes Switzerland (insurance activities)
*
* Asia, Africa & EME-LATAM:
** Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings are fully consolidated.
** Asia: China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024, and holding) businesses are consolidated under the equity method and contribute only to NBV, PVEP, [[Definition:Underlying earnings|underlying earnings]], and net income.
** Africa: Morocco (insurance activities and holding), Nigeria (insurance activities and holding), and Egypt (insurance activities and holding) are fully consolidated.
** EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) are fully consolidated.
** EME-LATAM: Russia (Reso) (insurance activities) is consolidated under the equity method and contributes only to net income.
**
* Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings.
* [[Definition:AXA Investment Managers|AXA Investment Managers]] (until July 1, 2025): includes AXA Investment Managers, Select (previously Architas), and Capza which are fully consolidated, and Asian joint ventures which are consolidated under the equity method.
{{chunk|doc=snjra2xp9r|c=
====== Accounting standards ======
* All comparative figures going back to 2023 are under IFRS17/9 accounting standards, effective January 1, 2023, unless otherwise specified.
* Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4.
=== Glossary ===
{{chunk|doc=snjra2xp9r|c=
====== Glossary of financial terms ======
* Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only, or with guarantees equal to or lower than 0%
* Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders
* CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period
* Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force
* Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder’s equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow
* [[Definition:Gross written premiums|Gross Written Premiums]] and [[Definition:Other revenue|Other Revenues]] ([[Definition:Gross written premiums & other revenues|GWP & Other Revenues]]): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business)
** Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities)
* New Business Value (NBV): the value of newly issued contracts during the current year
** It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests
* New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided
* New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP
* Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes
** Operating variance is net of reinsurance
* Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term
** PVEP is discounted at the reference interest rate and PVEP is Group share
* Technical experience: consists of the impacts on the [[Definition:Underlying earnings|underlying earnings]] if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses
* Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance
{{chunk|doc=snjra2xp9r|c=
======
* [[Definition:Full year 2025|Full Year 2025]] Earnings presentation was on February 26, [[Definition:Year 2026|2026]].
| |||